statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	20.283
EU - Europa	11.434
AS - Asia	7.340
SA - Sud America	1.291
Continente sconosciuto - Info sul continente non disponibili	500
AF - Africa	138
OC - Oceania	8
Totale	40.994

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	20.028
IT - Italia	6.463
SG - Singapore	2.898
UA - Ucraina	1.671
CN - Cina	1.416
VN - Vietnam	1.307
HK - Hong Kong	1.104
BR - Brasile	1.079
IE - Irlanda	744
DE - Germania	635
GB - Regno Unito	449
SE - Svezia	404
FR - Francia	396
RU - Federazione Russa	342
BD - Bangladesh	121
FI - Finlandia	116
TR - Turchia	96
CA - Canada	93
IN - India	93
MX - Messico	89
AR - Argentina	86
JP - Giappone	77
ID - Indonesia	45
ZA - Sudafrica	35
EC - Ecuador	33
CO - Colombia	31
ES - Italia	31
NG - Nigeria	31
PK - Pakistan	31
AT - Austria	30
PL - Polonia	30
IQ - Iraq	29
NL - Olanda	29
KE - Kenya	17
MA - Marocco	17
SA - Arabia Saudita	17
UZ - Uzbekistan	17
PY - Paraguay	16
JM - Giamaica	15
MY - Malesia	15
VE - Venezuela	15
TT - Trinidad e Tobago	14
PH - Filippine	12
CZ - Repubblica Ceca	11
LT - Lituania	11
CH - Svizzera	10
CL - Cile	10
HN - Honduras	10
PE - Perù	9
TN - Tunisia	9
BE - Belgio	8
CR - Costa Rica	8
EG - Egitto	8
HU - Ungheria	8
DO - Repubblica Dominicana	7
DZ - Algeria	7
MD - Moldavia	7
RO - Romania	7
UY - Uruguay	7
AE - Emirati Arabi Uniti	6
AU - Australia	6
GT - Guatemala	6
AL - Albania	5
BY - Bielorussia	5
IL - Israele	5
NP - Nepal	5
BO - Bolivia	4
ET - Etiopia	4
GR - Grecia	4
KR - Corea	4
KZ - Kazakistan	4
OM - Oman	4
PR - Porto Rico	4
AM - Armenia	3
BG - Bulgaria	3
DK - Danimarca	3
EU - Europa	3
JO - Giordania	3
KH - Cambogia	3
LB - Libano	3
MM - Myanmar	3
NI - Nicaragua	3
TW - Taiwan	3
AZ - Azerbaigian	2
BB - Barbados	2
CG - Congo	2
GE - Georgia	2
HR - Croazia	2
RS - Serbia	2
SN - Senegal	2
SX - ???statistics.table.value.countryCode.SX???	2
TH - Thailandia	2
AO - Angola	1
BH - Bahrain	1
BJ - Benin	1
BN - Brunei Darussalam	1
BW - Botswana	1
CI - Costa d'Avorio	1
CW - ???statistics.table.value.countryCode.CW???	1
EE - Estonia	1
Totale	40.476

Salva come PNG Salva come JPEG

Città	#
Milan	4.694
Fairfield	2.726
Ashburn	2.343
San Jose	1.641
Singapore	1.451
Woodbridge	1.282
Hong Kong	1.095
Seattle	1.093
Wilmington	1.038
Houston	1.029
Cambridge	930
Jacksonville	882
Dublin	730
Princeton	646
Council Bluffs	522
Rome	467
The Dalles	454
Dallas	448
Boardman	429
Ann Arbor	398
Chandler	390
Beijing	346
Lauterbourg	344
Dong Ket	327
Ho Chi Minh City	255
Nyköping	231
San Diego	219
Washington	204
Chicago	198
Los Angeles	173
New York	172
London	155
Hanoi	153
Santa Clara	141
Ogden	135
Helsinki	102
São Paulo	81
Tokyo	73
Kocaeli	53
Mexico City	51
Como	47
Guangzhou	46
Orem	45
Shanghai	45
Salt Lake City	43
Buffalo	42
Rio de Janeiro	37
Atlanta	36
Brooklyn	36
Munich	36
Chennai	31
Haiphong	29
Hangzhou	29
Belo Horizonte	28
Frankfurt am Main	28
Abuja	27
San Francisco	27
Des Moines	26
Nuremberg	26
Tampa	26
Da Nang	24
Phoenix	24
Warsaw	24
Brasília	23
Johannesburg	23
Norwalk	23
Stockholm	23
Montreal	22
Prescot	22
Denver	21
Elk Grove Village	21
Porto Alegre	21
Toronto	20
Boston	18
Kilburn	18
Las Vegas	18
Vienna	18
Zhengzhou	18
Biên Hòa	17
Treviglio	17
Amsterdam	16
Hefei	16
Hải Dương	16
Kunming	16
Miami	16
Redmond	16
Tashkent	15
Lancaster	14
Manchester	14
Shenzhen	14
Thái Nguyên	14
Charlotte	13
Chiswick	13
Curitiba	13
Nairobi	13
Nanjing	13
Baghdad	12
Fortaleza	12
Istanbul	12
Redwood City	12
Totale	29.486

Salva come PNG Salva come JPEG

Nome	#
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	279
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	221
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	205
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	202
Fibrillazione atriale e morte cardiaca improvvisa: Un mistero da risolvere?	200
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	199
Association between periodontal disease and left ventricle mass in essential hypertension	195
The revolution of the anti-diabetic drugs in cardiology	189
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	174
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	168
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients	168
Microcirculation and left-ventricular hypertrophy	163
Good news for beta-blockers in perioperative medicine	162
Adverse prognostic significance of new diabetes in treated hypertensive subjects	160
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	159
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	157
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study	157
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	153
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	152
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	152
Ablation of atrial tachycardia in the setting of prior mitral valve surgery	152
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	150
Therapy of Type 2 diabetes: more gliflozines and less metformin?	149
Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease	147
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	146
Sudden Cardiac Death in Hypertensive Patients	146
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	146
The optimal blood pressure target for patients with coronary artery disease	145
How important is to reduce sodium and increase potassium in patients with hypertension?	144
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	143
Angiotensin-converting enzyme inhibitors	141
Electrocardiographic features of patients with COVID-19 pneumonia	141
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	140
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	140
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	140
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	140
Atrial fibrillation in hypertension - Predictors and outcome	139
Modernization and hypertension: is the link changing?	139
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	138
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	138
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	137
Role of ambulatory blood pressure monitoring in prehypertension	136
Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial	136
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects	136
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection	136
Telmisartan for the reduction of cardiovascular morbidity and mortality	135
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	135
Short- and long-term incidence of stroke in white-coat hypertension	134
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	134
The emerging role of high-density lipoprotein cholesterol in hypertension trials	133
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	133
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	133
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	132
Ambulatory blood pressure for cardiovascular risk stratification	132
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	132
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	132
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	131
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	131
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	131
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	131
White-coat hypertension in adults	130
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	130
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	130
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	130
Aliskiren versus ramipril in hypertension	130
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	130
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	130
Adverse prognostic significance of new diabetes in treated hypertensive subjects	130
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	130
COVID-19: ACE2centric infective disease?	130
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	129
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	129
"From Apennines to Andes:" Does Body Mass Index Affect the Relationship Between Age and Blood Pressure?	129
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	128
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	128
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	128
ABPM in the prognostic evaluation of hypertensive patients	127
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	127
Does Malaria Cause Hypertension?	127
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	127
The clinical significance of white-coat and masked hypertension	127
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	127
Natural history of hypertension subtypes	126
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	126
Catheter ablation of atrial tachycardias after mitral valve surgery: A systematic review and meta-analysis	126
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	125
New-onset diabetes in treated hypertensive patients	125
ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus	125
Estimate of white-coat effect and arterial stiffness	124
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	124
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons	123
"The Lower the BP the Better" Paradigm in the Elderly Vanished by VALISH?	123
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	123
EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION	123
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty?	123
Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective	123
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	122
European and US guidelines for arterial hypertension: similarities and differences	122
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients	122
Raas inhibitors and risk of COVID-19	122
Totale	14.209

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	205.090
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	205.090

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.555	0	503	59	87	82	120	182	219	193	442	304	364
2022/2023	1.998	338	75	81	143	90	508	15	228	242	168	56	54
2023/2024	7.937	1.109	1.235	1.190	1.475	1.744	767	45	61	198	39	11	63
2024/2025	4.485	15	41	924	82	79	264	181	167	655	270	402	1.405
2025/2026	10.557	678	587	683	1.732	512	435	2.123	809	1.452	692	526	328
2026/2027	892	390	502	0	0	0	0	0	0	0	0	0	0
Totale													40.994